Dems Side With FDA On Generic Drug Labeling Overhaul

Law360, Chicago (March 5, 2014, 7:03 PM EST) -- Congressional Democrats on Wednesday threw their support behind the U.S. Food and Drug Administration’s controversial plan to let generic drugmakers independently change their warning labels, saying the proposed rule would promote public safety.

In a letter to FDA Commissioner Margaret Hamburg, 41 Democrats from both the House and Senate said that current rules preventing generic drugmakers from updating labels without prior FDA approval negatively impact their constituents.

Among the lawmakers signing the letter were Sens. Patrick Leahy, D-Vt., and Tom Harkin, D-Iowa, and Reps. Henry Waxman,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.